{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:26:59Z","timestamp":1784093219643,"version":"3.55.0"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T00:00:00Z","timestamp":1550448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"NIH","award":["AG052005"],"award-info":[{"award-number":["AG052005"]}]},{"name":"NIH","award":["AG052986"],"award-info":[{"award-number":["AG052986"]}]},{"name":"NIH","award":["AG051459"],"award-info":[{"award-number":["AG051459"]}]},{"name":"NIH","award":["DK111178"],"award-info":[{"award-number":["DK111178"]}]},{"name":"NIH","award":["NKFI-126998"],"award-info":[{"award-number":["NKFI-126998"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.molmet.2019.02.005","type":"journal-article","created":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T13:16:01Z","timestamp":1550927761000},"page":"120-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Dopamine neuronal protection in the mouse Substantia nigra by GHSR is independent of electric activity"],"prefix":"10.1016","volume":"24","author":[{"given":"Bernardo","family":"Stutz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Nasrallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4418-8119","authenticated-orcid":false,"given":"Daniel","family":"Curry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Wu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Bing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Elsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat","family":"Mintz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas L.","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.molmet.2019.02.005_bib1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4103\/0019-5049.82658","article-title":"Parkinson's disease and anaesthesia","volume":"55","author":"Shaikh","year":"2011","journal-title":"Indian Journal of Anaesthesia"},{"issue":"5","key":"10.1016\/j.molmet.2019.02.005_bib2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.molmet.2019.02.005_bib3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.molmet.2019.02.005_bib4","first-page":"1","article-title":"Thirty years of dopamine research","volume":"60","author":"Carlsson","year":"1993","journal-title":"Advances in Neurology"},{"key":"10.1016\/j.molmet.2019.02.005_bib5","first-page":"140","article-title":"Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms","volume":"60","author":"Hornykiewicz","year":"1993","journal-title":"Advances in Neurology"},{"issue":"1","key":"10.1016\/j.molmet.2019.02.005_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/mds.26102","article-title":"The medical treatment of Parkinson disease from James Parkinson to George Cotzias","volume":"30","author":"Fahn","year":"2015","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1016\/j.molmet.2019.02.005_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrn3745","article-title":"Neurobiology of food intake in health and disease","volume":"15","author":"Morton","year":"2014","journal-title":"Nature Reviews Neuroscience"},{"issue":"5","key":"10.1016\/j.molmet.2019.02.005_bib8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cmet.2008.03.007","article-title":"Ghrelin modulates brain activity in areas that control appetitive behavior","volume":"7","author":"Malik","year":"2008","journal-title":"Cell Metabolism"},{"issue":"8","key":"10.1016\/j.molmet.2019.02.005_bib9","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2174\/1568026033452230","article-title":"Ghrelin in hypothalamic regulation of energy balance","volume":"3","author":"Horvath","year":"2003","journal-title":"Current Topics in Medicinal Chemistry"},{"issue":"3","key":"10.1016\/j.molmet.2019.02.005_bib10","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/cne.20823","article-title":"Expression of ghrelin receptor mRNA in the rat and the mouse brain","volume":"494","author":"Zigman","year":"2006","journal-title":"Journal of Comparative Neurology"},{"issue":"2","key":"10.1016\/j.molmet.2019.02.005_bib11","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.expneurol.2008.05.006","article-title":"Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra","volume":"212","author":"Jiang","year":"2008","journal-title":"Experimental Neurology"},{"issue":"45","key":"10.1016\/j.molmet.2019.02.005_bib12","doi-asserted-by":"crossref","first-page":"14057","DOI":"10.1523\/JNEUROSCI.3890-09.2009","article-title":"Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism","volume":"29","author":"Andrews","year":"2009","journal-title":"Journal of Neuroscience"},{"issue":"1","key":"10.1016\/j.molmet.2019.02.005_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/2042018813479645","article-title":"Ghrelin is neuroprotective in Parkinson's disease: molecular mechanisms of metabolic neuroprotection","volume":"4","author":"Bayliss","year":"2013","journal-title":"Therapeutic Advances in Endocrinology and Metabolism"},{"issue":"10","key":"10.1016\/j.molmet.2019.02.005_bib14","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1523\/JNEUROSCI.4373-15.2016","article-title":"Ghrelin-AMPK signaling mediates the neuroprotective effects of calorie restriction in Parkinson's disease","volume":"36","author":"Bayliss","year":"2016","journal-title":"Journal of Neuroscience"},{"issue":"1","key":"10.1016\/j.molmet.2019.02.005_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mce.2011.04.019","article-title":"The effects of ghrelin on inflammation and the immune system","volume":"340","author":"Baatar","year":"2011","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"2","key":"10.1016\/j.molmet.2019.02.005_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/AAP.0000000000000050","article-title":"Ghrelin alleviates neuropathic pain through GHSR-1a-mediated suppression of the p38 MAPK\/NF-kappaB pathway in a rat chronic constriction injury model","volume":"39","author":"Zhou","year":"2014","journal-title":"Regional Anesthesia and Pain Medicine"},{"key":"10.1016\/j.molmet.2019.02.005_bib17","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.neuroscience.2014.10.037","article-title":"Dopamine midbrain neurons in health and Parkinson's disease: emerging roles of voltage-gated calcium channels and ATP-sensitive potassium channels","volume":"284","author":"Dragicevic","year":"2015","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.molmet.2019.02.005_bib18","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1096\/fj.12-220418","article-title":"Specific needs of dopamine neurons for stimulation in order to survive: implication for Parkinson disease","volume":"27","author":"Michel","year":"2013","journal-title":"The FASEB Journal"},{"issue":"26","key":"10.1016\/j.molmet.2019.02.005_bib19","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1523\/JNEUROSCI.5668-03.2004","article-title":"Rescue of mesencephalic dopaminergic neurons in culture by low-level stimulation of voltage-gated sodium channels","volume":"24","author":"Salthun-Lassalle","year":"2004","journal-title":"Journal of Neuroscience"},{"issue":"3","key":"10.1016\/j.molmet.2019.02.005_bib20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0306-4522(85)90141-1","article-title":"Regulation of dopamine release by impulse flow and by autoreceptors as studied by in\u00a0vivo voltammetry in the rat striatum","volume":"14","author":"Gonon","year":"1985","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.molmet.2019.02.005_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1471-4159.2006.04424.x","article-title":"Role of activity-dependent mechanisms in the control of dopaminergic neuron survival","volume":"101","author":"Michel","year":"2007","journal-title":"Journal of Neurochemistry"},{"issue":"9","key":"10.1016\/j.molmet.2019.02.005_bib22","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb2329","article-title":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism","volume":"13","author":"Mihaylova","year":"2011","journal-title":"Nature Cell Biology"},{"issue":"25","key":"10.1016\/j.molmet.2019.02.005_bib23","doi-asserted-by":"crossref","first-page":"10190","DOI":"10.1073\/pnas.1107402108","article-title":"Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation","volume":"108","author":"Rambold","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/j.molmet.2019.02.005_bib24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/ncb2220","article-title":"During autophagy mitochondria elongate, are spared from degradation and sustain cell viability","volume":"13","author":"Gomes","year":"2011","journal-title":"Nature Cell Biology"},{"issue":"5","key":"10.1016\/j.molmet.2019.02.005_bib25","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.devcel.2006.10.009","article-title":"Dissecting mitochondrial fusion","volume":"11","author":"Chan","year":"2006","journal-title":"Developmental Cell"},{"issue":"8","key":"10.1016\/j.molmet.2019.02.005_bib26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrm1697","article-title":"Mitochondrial fission in apoptosis","volume":"6","author":"Youle","year":"2005","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"2","key":"10.1016\/j.molmet.2019.02.005_bib27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tcb.2012.10.006","article-title":"Mitochondrial dynamics in neurodegeneration","volume":"23","author":"Itoh","year":"2013","journal-title":"Trends in Cell Biology"},{"issue":"23","key":"10.1016\/j.molmet.2019.02.005_bib28","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1056\/NEJMra1215233","article-title":"Mitochondrial dynamics--mitochondrial fission and fusion in human diseases","volume":"369","author":"Archer","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.molmet.2019.02.005_bib29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrn2417","article-title":"Mitochondrial fragmentation in neurodegeneration","volume":"9","author":"Knott","year":"2008","journal-title":"Nature Reviews Neuroscience"},{"issue":"Suppl 2","key":"10.1016\/j.molmet.2019.02.005_bib30","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.3233\/JAD-2010-100363","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"20","author":"Zhu","year":"2010","journal-title":"Journal of Alzheimers Disease"},{"issue":"Suppl 1","key":"10.1016\/j.molmet.2019.02.005_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/jnc.13696","article-title":"Molecular changes in the postmortem parkinsonian brain","volume":"139","author":"Toulorge","year":"2016","journal-title":"Journal of Neurochemistry"},{"issue":"6","key":"10.1016\/j.molmet.2019.02.005_bib32","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.bbadis.2017.02.016","article-title":"Mfn2 protects dopaminergic neurons exposed to paraquat both in\u00a0vitro and in\u00a0vivo: implications for idiopathic Parkinson's disease","volume":"1863","author":"Zhao","year":"2017","journal-title":"Biochimica et Biophysica Acta"},{"issue":"Suppl 17","key":"10.1016\/j.molmet.2019.02.005_bib33","doi-asserted-by":"crossref","first-page":"S343","DOI":"10.1002\/mds.21676","article-title":"Update on the genetics of Parkinson's disease","volume":"22","author":"Gasser","year":"2007","journal-title":"Movement Disorders"},{"issue":"10","key":"10.1016\/j.molmet.2019.02.005_bib34","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009324","article-title":"Animal models of Parkinson's disease: vertebrate genetics","volume":"2","author":"Lee","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"5","key":"10.1016\/j.molmet.2019.02.005_bib35","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng1769","article-title":"High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease","volume":"38","author":"Bender","year":"2006","journal-title":"Nature Genetics"},{"issue":"5","key":"10.1016\/j.molmet.2019.02.005_bib36","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/ng1778","article-title":"Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons","volume":"38","author":"Kraytsberg","year":"2006","journal-title":"Nature Genetics"},{"issue":"7","key":"10.1016\/j.molmet.2019.02.005_bib37","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/WNL.35.7.949","article-title":"Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases","volume":"35","author":"Ballard","year":"1985","journal-title":"Neurology"},{"issue":"s1","key":"10.1016\/j.molmet.2019.02.005_bib38","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.3233\/JPD-179006","article-title":"The MPTP story","volume":"7","author":"Langston","year":"2017","journal-title":"Journal of Parkinson's Disease"},{"issue":"3","key":"10.1016\/j.molmet.2019.02.005_bib39","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"54","author":"Schapira","year":"1990","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/j.molmet.2019.02.005_bib40","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cell.2013.09.004","article-title":"Mitochondrial dynamics controlled by mitofusins regulate Agrp neuronal activity and diet-induced obesity","volume":"155","author":"Dietrich","year":"2013","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.molmet.2019.02.005_bib41","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1172\/JCI29867","article-title":"Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite","volume":"116","author":"Abizaid","year":"2006","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.molmet.2019.02.005_bib42","series-title":"The mouse brain in stereotaxic coordinates","first-page":"256","author":"Paxinos","year":"2001"},{"issue":"6","key":"10.1016\/j.molmet.2019.02.005_bib43","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/jnc.12475","article-title":"Murine dopaminergic Muller cells restore motor function in a model of Parkinson's disease","volume":"128","author":"Stutz","year":"2014","journal-title":"Journal of Neurochemistry"},{"issue":"6762","key":"10.1016\/j.molmet.2019.02.005_bib44","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.molmet.2019.02.005_bib45","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1210\/jcem.87.6.8739","article-title":"The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans","volume":"87","author":"Gnanapavan","year":"2002","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"11","key":"10.1016\/j.molmet.2019.02.005_bib46","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.peptides.2011.07.024","article-title":"Structures and molecular forms of the ghrelin-family peptides","volume":"32","author":"Nishi","year":"2011","journal-title":"Peptides"},{"issue":"17","key":"10.1016\/j.molmet.2019.02.005_bib47","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.1073\/pnas.0800708105","article-title":"Ghrelin octanoylation mediated by an orphan lipid transferase","volume":"105","author":"Gutierrez","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/j.molmet.2019.02.005_bib48","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2008.01.017","article-title":"Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone","volume":"132","author":"Yang","year":"2008","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.molmet.2019.02.005_bib49","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1210\/en.2010-0412","article-title":"Identification and characterization of acyl-protein thioesterase 1\/lysophospholipase I as a ghrelin deacylation\/lysophospholipid hydrolyzing enzyme in fetal bovine serum and conditioned medium","volume":"151","author":"Satou","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2019.02.005_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2011.07.063","article-title":"Investigation of the presence of ghrelin in the central nervous system of the rat and mouse","volume":"193","author":"Furness","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.molmet.2019.02.005_bib51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.npep.2015.04.003","article-title":"The number of preproghrelin mRNA expressing cells is increased in mice with activity-based anorexia","volume":"51","author":"Francois","year":"2015","journal-title":"Neuropeptides"},{"issue":"3","key":"10.1016\/j.molmet.2019.02.005_bib52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(01)02544-7","article-title":"Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus","volume":"321","author":"Lu","year":"2002","journal-title":"Neuroscience Letters"},{"issue":"1\u20133","key":"10.1016\/j.molmet.2019.02.005_bib53","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.regpep.2007.09.026","article-title":"Visualization of ghrelin-producing neurons in the hypothalamic arcuate nucleus using ghrelin-EGFP transgenic mice","volume":"145","author":"Kageyama","year":"2008","journal-title":"Regulatory Peptides"},{"issue":"4","key":"10.1016\/j.molmet.2019.02.005_bib54","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0896-6273(03)00063-1","article-title":"The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis","volume":"37","author":"Cowley","year":"2003","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.molmet.2019.02.005_bib55","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1097\/01.ASN.0000032420.12455.74","article-title":"Plasma ghrelin and desacyl ghrelin concentrations in renal failure","volume":"13","author":"Yoshimoto","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1016\/j.molmet.2019.02.005_bib56","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1210\/jc.2004-1641","article-title":"Characterization of ghrelin-like immunoreactivity in human plasma","volume":"90","author":"Patterson","year":"2005","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"6","key":"10.1016\/j.molmet.2019.02.005_bib57","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1530\/EJE-13-0072","article-title":"The pharmacokinetics of acyl, des-acyl, and total ghrelin in healthy human subjects","volume":"168","author":"Tong","year":"2013","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.molmet.2019.02.005_bib58","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.molmet.2018.09.007","article-title":"Ghrelin transport across the blood-brain barrier can occur independently of the growth hormone secretagogue receptor","volume":"18","author":"Rhea","year":"2018","journal-title":"Molecular Metabolism"},{"issue":"3","key":"10.1016\/j.molmet.2019.02.005_bib59","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1677\/JOE-08-0160","article-title":"Phosphatidylinositol-3-kinase\/Akt\/glycogen synthase kinase-3 beta and ERK1\/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells","volume":"198","author":"Chung","year":"2008","journal-title":"Journal of Endocrinology"},{"issue":"12","key":"10.1016\/j.molmet.2019.02.005_bib60","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1002\/jnr.22088","article-title":"Desacyl-ghrelin and synthetic GH-secretagogues modulate the production of inflammatory cytokines in mouse microglia cells stimulated by beta-amyloid fibrils","volume":"87","author":"Bulgarelli","year":"2009","journal-title":"Journal of Neuroscience Research"},{"issue":"3","key":"10.1016\/j.molmet.2019.02.005_bib61","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/jnc.13576","article-title":"Acylated but not des-acyl ghrelin is neuroprotective in an MPTP mouse model of Parkinson's Disease","volume":"137","author":"Bayliss","year":"2016","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.molmet.2019.02.005_bib62","doi-asserted-by":"crossref","first-page":"45541","DOI":"10.1038\/srep45541","article-title":"Unacylated ghrelin promotes adipogenesis in rodent bone marrow via ghrelin O-acyl transferase and GHS-R1a activity: evidence for target cell-induced acylation","volume":"7","author":"Hopkins","year":"2017","journal-title":"Scientific Reports"},{"issue":"8","key":"10.1016\/j.molmet.2019.02.005_bib63","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1507\/endocrj.K11E-117","article-title":"The expression of ghrelin O-acyltransferase (GOAT) in human tissues","volume":"58","author":"Lim","year":"2011","journal-title":"Endocrine Journal"},{"issue":"11","key":"10.1016\/j.molmet.2019.02.005_bib64","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.peptides.2011.09.019","article-title":"Role of ghrelin system in neuroprotection and cognitive functions: implications in Alzheimer's disease","volume":"32","author":"Gahete","year":"2011","journal-title":"Peptides"},{"issue":"1\u20132","key":"10.1016\/j.molmet.2019.02.005_bib65","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.mce.2009.12.023","article-title":"Metabolic regulation of ghrelin O-acyl transferase (GOAT) expression in the mouse hypothalamus, pituitary, and stomach","volume":"317","author":"Gahete","year":"2010","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"1","key":"10.1016\/j.molmet.2019.02.005_bib66","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/jnc.14244","article-title":"Endogenous ghrelin-O-acyltransferase (GOAT) acylates local ghrelin in the hippocampus","volume":"144","author":"Murtuza","year":"2018","journal-title":"Journal of Neurochemistry"},{"issue":"3","key":"10.1016\/j.molmet.2019.02.005_bib67","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3803\/EnM.2014.29.3.371","article-title":"Ghrelin inhibits oligodendrocyte cell death by attenuating microglial activation","volume":"29","author":"Lee","year":"2014","journal-title":"Endocrinology and Metabolism (Seoul)"},{"issue":"1","key":"10.1016\/j.molmet.2019.02.005_bib68","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11033-012-1993-1","article-title":"Acylated ghrelin protects hippocampal neurons in pilocarpine-induced seizures of immature rats by inhibiting cell apoptosis","volume":"40","author":"Zhang","year":"2013","journal-title":"Molecular Biology Reports"},{"key":"10.1016\/j.molmet.2019.02.005_bib69","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1742-2094-10-40","article-title":"Ghrelin inhibits LPS-induced release of IL-6 from mouse dopaminergic neurones","volume":"10","author":"Beynon","year":"2013","journal-title":"Journal of Neuroinflammation"},{"issue":"2","key":"10.1016\/j.molmet.2019.02.005_bib70","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbrc.2007.05.118","article-title":"Ghrelin inhibits apoptosis signal-regulating kinase 1 activity via upregulating heat-shock protein 70","volume":"359","author":"Yang","year":"2007","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1","key":"10.1016\/j.molmet.2019.02.005_bib71","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/en.2006-0991","article-title":"Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation","volume":"148","author":"Chung","year":"2007","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.molmet.2019.02.005_bib72","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3233\/JAD-2010-101263","article-title":"Ghrelin ameliorates cognitive dysfunction and neurodegeneration in intrahippocampal amyloid-beta1-42 oligomer-injected mice","volume":"23","author":"Moon","year":"2011","journal-title":"Journal of Alzheimers Disease"},{"issue":"3","key":"10.1016\/j.molmet.2019.02.005_bib73","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.bbrc.2007.05.192","article-title":"Ghrelin protects cortical neuron against focal ischemia\/reperfusion in rats","volume":"359","author":"Miao","year":"2007","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"3","key":"10.1016\/j.molmet.2019.02.005_bib74","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1677\/JOE-10-0040","article-title":"Ghrelin attenuates kainic acid-induced neuronal cell death in the mouse hippocampus","volume":"205","author":"Lee","year":"2010","journal-title":"Journal of Endocrinology"},{"issue":"11","key":"10.1016\/j.molmet.2019.02.005_bib75","doi-asserted-by":"crossref","first-page":"R980","DOI":"10.1152\/ajpregu.00594.2012","article-title":"Endogenous ghrelin's role in hippocampal neuroprotection after global cerebral ischemia: does endogenous ghrelin protect against global stroke?","volume":"304","author":"Kenny","year":"2013","journal-title":"American Journal of Physiology Regulatory Integrative and Comparative Physiology"},{"issue":"1","key":"10.1016\/j.molmet.2019.02.005_bib76","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3233\/JAD-132417","article-title":"Impaired hippocampal neurogenesis and its enhancement with ghrelin in 5XFAD mice","volume":"41","author":"Moon","year":"2014","journal-title":"Journal of Alzheimers Disease"},{"issue":"4","key":"10.1016\/j.molmet.2019.02.005_bib77","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s12640-009-9037-x","article-title":"Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation","volume":"15","author":"Moon","year":"2009","journal-title":"Neurotoxicity Research"},{"issue":"4","key":"10.1016\/j.molmet.2019.02.005_bib78","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.4049\/jimmunol.0803362","article-title":"Suppression of experimental autoimmune encephalomyelitis by ghrelin","volume":"183","author":"Theil","year":"2009","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.molmet.2019.02.005_bib79","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbi.2013.01.080","article-title":"Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1\/Th17 responses and inducing regulatory T cells","volume":"30","author":"Souza-Moreira","year":"2013","journal-title":"Brain Behavior and Immunity"},{"issue":"8","key":"10.1016\/j.molmet.2019.02.005_bib80","doi-asserted-by":"crossref","first-page":"e72716","DOI":"10.1371\/journal.pone.0072716","article-title":"Protective but not anticonvulsant effects of ghrelin and JMV-1843 in the pilocarpine model of Status epilepticus","volume":"8","author":"Lucchi","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.molmet.2019.02.005_bib81","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1528-1167.2012.03423.x","article-title":"Ghrelin: an emerging new anticonvulsant neuropeptide","volume":"53","author":"Portelli","year":"2012","journal-title":"Epilepsia"},{"issue":"12 Pt A","key":"10.1016\/j.molmet.2019.02.005_bib82","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.bbadis.2014.09.006","article-title":"Ghrelin inhibits BSCB disruption\/hemorrhage by attenuating MMP-9 and SUR1\/TrpM4 expression and activation after spinal cord injury","volume":"1842","author":"Lee","year":"2014","journal-title":"Biochimica et Biophysica Acta"},{"issue":"11","key":"10.1016\/j.molmet.2019.02.005_bib83","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1210\/me.2003-0069","article-title":"High constitutive signaling of the ghrelin receptor--identification of a potent inverse agonist","volume":"17","author":"Holst","year":"2003","journal-title":"Molecular Endocrinology"},{"issue":"11","key":"10.1016\/j.molmet.2019.02.005_bib84","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.peptides.2011.07.002","article-title":"Stress-related alterations of acyl and desacyl ghrelin circulating levels: mechanisms and functional implications","volume":"32","author":"Stengel","year":"2011","journal-title":"Peptides"},{"issue":"2","key":"10.1016\/j.molmet.2019.02.005_bib85","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neuron.2011.10.038","article-title":"Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism","volume":"73","author":"Kern","year":"2012","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.molmet.2019.02.005_bib86","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1074\/jbc.M112.382473","article-title":"Promiscuous dimerization of the growth hormone secretagogue receptor (GHS-R1a) attenuates ghrelin-mediated signaling","volume":"288","author":"Schellekens","year":"2013","journal-title":"Journal of Biological Chemistry"},{"issue":"12","key":"10.1016\/j.molmet.2019.02.005_bib87","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1210\/en.2014-1497","article-title":"Assessing interactions between Ghsr and Mc3r reveals a role for AgRP in the expression of food anticipatory activity in male mice","volume":"155","author":"Girardet","year":"2014","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.molmet.2019.02.005_bib88","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.cell.2015.10.062","article-title":"Hippocampal dopamine\/DRD1 signaling dependent on the ghrelin receptor","volume":"163","author":"Kern","year":"2015","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.molmet.2019.02.005_bib89","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/JPD-171296","article-title":"Targeting AMPK signaling as a neuroprotective strategy in Parkinson's disease","volume":"8","author":"Curry","year":"2018","journal-title":"Journal of Parkinson's Disease"},{"issue":"7","key":"10.1016\/j.molmet.2019.02.005_bib90","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1172\/JCI25811","article-title":"Ghrelin action in the brain controls adipocyte metabolism","volume":"116","author":"Theander-Carrillo","year":"2006","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.molmet.2019.02.005_bib91","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/7854_2014_356","article-title":"Neuroinflammation in Parkinson's disease animal models: a cell stress response or a step in neurodegeneration?","volume":"22","author":"Cebrian","year":"2015","journal-title":"Current Topics in Behavioral Neurosciences"},{"issue":"52","key":"10.1016\/j.molmet.2019.02.005_bib92","doi-asserted-by":"crossref","first-page":"19126","DOI":"10.1073\/pnas.0508215102","article-title":"Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage","volume":"102","author":"Perier","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"13","key":"10.1016\/j.molmet.2019.02.005_bib93","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1073\/pnas.95.13.7659","article-title":"Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"95","author":"Ara","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1\u20132","key":"10.1016\/j.molmet.2019.02.005_bib94","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jnr.20285","article-title":"Nitric oxide from inflammatory-activated glia synergizes with hypoxia to induce neuronal death","volume":"79","author":"Mander","year":"2005","journal-title":"Journal of Neuroscience Research"},{"issue":"2","key":"10.1016\/j.molmet.2019.02.005_bib95","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/neur.1996.0020","article-title":"Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model","volume":"5","author":"Czlonkowska","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.molmet.2019.02.005_bib96","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fnagi.2017.00176","article-title":"Targeting microglial activation states as a therapeutic Avenue in Parkinson's disease","volume":"9","author":"Subramaniam","year":"2017","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1\u20132","key":"10.1016\/j.molmet.2019.02.005_bib97","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2008.08.003","article-title":"The effects of MPTP on the activation of microglia\/astrocytes and cytokine\/chemokine levels in different mice strains","volume":"204","author":"Yasuda","year":"2008","journal-title":"Journal of Neuroimmunology"},{"issue":"4","key":"10.1016\/j.molmet.2019.02.005_bib98","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"The Lancet Neurology"},{"issue":"1","key":"10.1016\/j.molmet.2019.02.005_bib99","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/j.molmet.2019.02.005_bib100","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.4049\/jimmunol.0901852","article-title":"Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease","volume":"184","author":"Reynolds","year":"2010","journal-title":"The Journal of Immunology"},{"issue":"1","key":"10.1016\/j.molmet.2019.02.005_bib101","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13024-017-0158-z","article-title":"Defining the contribution of neuroinflammation to Parkinson's disease in humanized immune system mice","volume":"12","author":"Manocha","year":"2017","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/j.molmet.2019.02.005_bib102","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1742-2094-8-91","article-title":"The PPAR-gamma agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys","volume":"8","author":"Swanson","year":"2011","journal-title":"Journal of Neuroinflammation"},{"issue":"11","key":"10.1016\/j.molmet.2019.02.005_bib103","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1096\/fj.02-0216fje","article-title":"Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease","volume":"16","author":"Sriram","year":"2002","journal-title":"The FASEB Journal"},{"issue":"1\u20132","key":"10.1016\/j.molmet.2019.02.005_bib104","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","article-title":"Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome","volume":"160","author":"Yan","year":"2015","journal-title":"Cell"},{"issue":"7435","key":"10.1016\/j.molmet.2019.02.005_bib105","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature11748","article-title":"Suppression of neuroinflammation by astrocytic dopamine D2 receptors via alphaB-crystallin","volume":"494","author":"Shao","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.molmet.2019.02.005_bib106","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0006-8993(91)90013-L","article-title":"Stimulus-evoked changes in neostriatal dopamine levels in awake and anesthetized rats as measured by microdialysis","volume":"559","author":"Tepper","year":"1991","journal-title":"Brain Research"},{"issue":"8","key":"10.1016\/j.molmet.2019.02.005_bib107","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1172\/JCI42642","article-title":"Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease","volume":"120","author":"Karachi","year":"2010","journal-title":"Journal of Clinical Investigation"},{"issue":"14","key":"10.1016\/j.molmet.2019.02.005_bib108","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1523\/JNEUROSCI.1395-15.2016","article-title":"Dopaminergic neurons exhibit an age-dependent decline in electrophysiological parameters in the MitoPark mouse model of Parkinson's disease","volume":"36","author":"Branch","year":"2016","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.molmet.2019.02.005_bib109","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroscience.2011.08.066","article-title":"Dopamine release in the basal ganglia","volume":"198","author":"Rice","year":"2011","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.molmet.2019.02.005_bib110","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1124\/mol.64.3.578","article-title":"Prevention of dopaminergic neuronal death by cyclic AMP in mixed neuronal\/glial mesencephalic cultures requires the repression of presumptive astrocytes","volume":"64","author":"Mourlevat","year":"2003","journal-title":"Molecular Pharmacology"},{"issue":"1","key":"10.1016\/j.molmet.2019.02.005_bib111","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1471-4159.2001.00401.x","article-title":"Survival promotion of mesencephalic dopaminergic neurons by depolarizing concentrations of K+ requires concurrent inactivation of NMDA or AMPA\/kainate receptors","volume":"78","author":"Douhou","year":"2001","journal-title":"Journal of Neurochemistry"},{"issue":"4","key":"10.1016\/j.molmet.2019.02.005_bib112","doi-asserted-by":"crossref","first-page":"e95297","DOI":"10.1371\/journal.pone.0095297","article-title":"A\u00a0case-control study of the protective effect of alcohol, coffee, and cigarette consumption on Parkinson disease risk: time-since-cessation modifies the effect of tobacco smoking","volume":"9","author":"van der Mark","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.molmet.2019.02.005_bib113","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's disease","volume":"5","author":"de Lau","year":"2006","journal-title":"The Lancet Neurology"},{"issue":"1\u20132","key":"10.1016\/j.molmet.2019.02.005_bib114","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0006-8993(03)03195-0","article-title":"Cigarette smoke and nicotine protect dopaminergic neurons against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinsonian toxin","volume":"984","author":"Parain","year":"2003","journal-title":"Brain Research"},{"issue":"2","key":"10.1016\/j.molmet.2019.02.005_bib115","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0006-8993(00)03198-X","article-title":"Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice","volume":"890","author":"Parain","year":"2001","journal-title":"Brain Research"},{"issue":"17","key":"10.1016\/j.molmet.2019.02.005_bib116","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1523\/JNEUROSCI.0215-06.2006","article-title":"Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates","volume":"26","author":"Quik","year":"2006","journal-title":"Journal of Neuroscience"},{"issue":"2","key":"10.1016\/j.molmet.2019.02.005_bib117","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/ng1095-126","article-title":"A\u00a0potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation","volume":"11","author":"Patil","year":"1995","journal-title":"Nature Genetics"},{"issue":"3","key":"10.1016\/j.molmet.2019.02.005_bib118","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0304-3940(01)01570-1","article-title":"Requirement of neural activity for the maintenance of dopaminergic neurons in rat midbrain slice cultures","volume":"300","author":"Katsuki","year":"2001","journal-title":"Neuroscience Letters"},{"issue":"12","key":"10.1016\/j.molmet.2019.02.005_bib119","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/nn1570","article-title":"K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons","volume":"8","author":"Liss","year":"2005","journal-title":"Nature Neuroscience"},{"issue":"43","key":"10.1016\/j.molmet.2019.02.005_bib120","doi-asserted-by":"crossref","first-page":"10029","DOI":"10.1523\/JNEUROSCI.2652-05.2005","article-title":"Partial mitochondrial inhibition causes striatal dopamine release suppression and medium spiny neuron depolarization via H2O2 elevation, not ATP depletion","volume":"25","author":"Bao","year":"2005","journal-title":"Journal of Neuroscience"},{"issue":"17","key":"10.1016\/j.molmet.2019.02.005_bib121","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1523\/JNEUROSCI.4701-04.2005","article-title":"Endogenous hydrogen peroxide regulates the excitability of midbrain dopamine neurons via ATP-sensitive potassium channels","volume":"25","author":"Avshalumov","year":"2005","journal-title":"Journal of Neuroscience"},{"issue":"7148","key":"10.1016\/j.molmet.2019.02.005_bib122","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nature05865","article-title":"'Rejuvenation' protects neurons in mouse models of Parkinson's disease","volume":"447","author":"Chan","year":"2007","journal-title":"Nature"},{"issue":"7631","key":"10.1016\/j.molmet.2019.02.005_bib123","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nature20156","article-title":"Correcting mitochondrial fusion by manipulating mitofusin conformations","volume":"540","author":"Franco","year":"2016","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1016\/j.molmet.2019.02.005_bib124","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"139","author":"Bose","year":"2016","journal-title":"Journal of Neurochemistry"},{"issue":"11","key":"10.1016\/j.molmet.2019.02.005_bib125","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ncpneuro0924","article-title":"Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis","volume":"4","author":"Henchcliffe","year":"2008","journal-title":"Nature Clinical Practice Neurology"},{"issue":"3","key":"10.1016\/j.molmet.2019.02.005_bib126","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/1073858415574600","article-title":"The Parkinson disease mitochondrial hypothesis: where are we at?","volume":"22","author":"Franco-Iborra","year":"2016","journal-title":"The Neuroscientist"},{"issue":"11","key":"10.1016\/j.molmet.2019.02.005_bib127","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nrm2275","article-title":"Functions and dysfunctions of mitochondrial dynamics","volume":"8","author":"Detmer","year":"2007","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"43","key":"10.1016\/j.molmet.2019.02.005_bib128","doi-asserted-by":"crossref","first-page":"14304","DOI":"10.1523\/JNEUROSCI.0930-14.2014","article-title":"Loss of mitochondrial fission depletes axonal mitochondria\u00a0in\u00a0midbrain dopamine neurons","volume":"34","author":"Berthet","year":"2014","journal-title":"Journal of Neuroscience"},{"issue":"24 Pt A","key":"10.1016\/j.molmet.2019.02.005_bib129","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1016\/j.febslet.2015.10.021","article-title":"Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease","volume":"589","author":"Haddad","year":"2015","journal-title":"FEBS Letters"},{"issue":"22","key":"10.1016\/j.molmet.2019.02.005_bib130","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1093\/hmg\/dds311","article-title":"Loss of Mfn2 results in progressive, retrograde degeneration of dopaminergic neurons in the nigrostriatal circuit","volume":"21","author":"Pham","year":"2012","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"10.1016\/j.molmet.2019.02.005_bib131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ana.24410","article-title":"Syndromic parkinsonism and dementia associated with OPA1 missense mutations","volume":"78","author":"Carelli","year":"2015","journal-title":"Annals of Neurology"},{"issue":"20","key":"10.1016\/j.molmet.2019.02.005_bib132","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1038\/emboj.2010.223","article-title":"Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, Parkin and DJ-1","volume":"29","author":"Kamp","year":"2010","journal-title":"The EMBO Journal"},{"issue":"15","key":"10.1016\/j.molmet.2019.02.005_bib133","doi-asserted-by":"crossref","first-page":"11740","DOI":"10.1074\/jbc.M109.066662","article-title":"Perturbations in mitochondrial dynamics induced by human mutant PINK1 can be rescued by the mitochondrial division inhibitor mdivi-1","volume":"285","author":"Cui","year":"2010","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.molmet.2019.02.005_bib134","doi-asserted-by":"crossref","first-page":"5244","DOI":"10.1038\/ncomms6244","article-title":"Drp1 inhibition attenuates neurotoxicity and dopamine release deficits in\u00a0vivo","volume":"5","author":"Rappold","year":"2014","journal-title":"Nature Communications"},{"issue":"14","key":"10.1016\/j.molmet.2019.02.005_bib135","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain","volume":"283","author":"Devi","year":"2008","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.molmet.2019.02.005_bib136","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainresbull.2017.03.009","article-title":"Metabolic dysfunction in Parkinson's disease: bioenergetics, redox homeostasis and central carbon metabolism","volume":"133","author":"Anandhan","year":"2017","journal-title":"Brain Research Bulletin"},{"issue":"18","key":"10.1016\/j.molmet.2019.02.005_bib137","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.cub.2015.07.050","article-title":"Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons","volume":"25","author":"Pacelli","year":"2015","journal-title":"Current Biology"},{"issue":"4","key":"10.1016\/j.molmet.2019.02.005_bib138","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2016.03.038","article-title":"Understanding dopaminergic cell death pathways in Parkinson disease","volume":"90","author":"Michel","year":"2016","journal-title":"Neuron"},{"issue":"7324","key":"10.1016\/j.molmet.2019.02.005_bib139","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nature09536","article-title":"Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1","volume":"468","author":"Guzman","year":"2010","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.molmet.2019.02.005_bib140","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1177\/1073858408322839","article-title":"Glial cells as players in parkinsonism: the \"good,\" the \"bad,\" and the \"mysterious\" glia","volume":"14","author":"Mena","year":"2008","journal-title":"The Neuroscientist"},{"issue":"13","key":"10.1016\/j.molmet.2019.02.005_bib141","article-title":"The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease","volume":"7","author":"Pissadaki","year":"2013","journal-title":"Frontiers in Computational Neuroscience"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877818312560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877818312560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:19:39Z","timestamp":1761956379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877818312560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":141,"alternative-id":["S2212877818312560"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2019.02.005","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopamine neuronal protection in the mouse Substantia nigra by GHSR is independent of electric activity","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2019.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}]}}